Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

57.76
Delayed Data
As of 4:00pm ET
 +0.63 / +1.10%
Today’s Change
10.71
Today|||52-Week Range
65.20
+361.34%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close57.13
Today’s open59.44
Day’s range56.71 - 61.38
Volume772,328
Average volume (3 months)626,138
Market cap$1.5B
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-47.35%
Earnings growth (this year)-119.75%
Earnings growth (next 5 years)+8.11%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.64

Competitors

 Today’s
change
Today’s
% change
GBTGlobal Blood Therape...+1.05+2.74%
TXMDTherapeuticsMD Inc-0.21-3.14%
BHVNBiohaven Pharmaceuti...-1.31-5.64%
FWPForward Pharma A/S+0.05+1.42%
Data as of 4:02pm ET, 12/14/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$1.78
Annual revenue (last year)$0.00
Annual profit (last year)-$75.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tim M. Mayleben
COO, Executive VP-Research &
Development
Narendra D. Lalwani
Corporate headquarters
Ann Arbor, Michigan

Forecasts